Acrivon Therapeutics Inc.... (ACRV)
5.64
0.08 (1.44%)
At close: Jan 15, 2025, 11:45 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Revenue | n/a | n/a | n/a | n/a |
| Cost of Revenue | 536.00K | 1.09M | 832.00K | 13.00K |
| Gross Profit | -536.00K | -1.09M | -832.00K | -13.00K |
| Operating Income | -67.24M | -32.66M | -16.18M | -3.17M |
| Interest Income | n/a | n/a | n/a | n/a |
| Pretax Income | -60.39M | -31.17M | -16.24M | -5.31M |
| Net Income | -60.39M | -29.68M | -16.24M | -5.31M |
| Selling & General & Admin | 21.21M | 8.71M | 2.47M | 1.30M |
| Research & Development | 45.49M | 23.95M | 13.72M | 1.87M |
| Other Expenses | n/a | 1.49M | -59.00K | -2.14M |
| Operating Expenses | 66.70M | 32.66M | 16.18M | 3.17M |
| Interest Expense | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | 134.00K | n/a | n/a | n/a |
| Cost & Expenses | 67.24M | 32.66M | 16.18M | 3.17M |
| Income Tax | n/a | -1.49M | -199.56K | -193.30K |
| Shares Outstanding (Basic) | 22.08M | 21.92M | 20.86M | 20.86M |
| Shares Outstanding (Diluted) | 22.08M | 21.92M | 20.86M | 20.86M |
| EPS (Basic) | -2.74 | -1.35 | -0.78 | -0.25 |
| EPS (Diluted) | -2.74 | -1.35 | -0.78 | -0.25 |
| EBITDA | -59.85M | -30.07M | -15.41M | -5.29M |
| Depreciation & Amortization | 536.00K | 1.09M | 832.00K | 13.00K |